FDA Inspection 1074309 — Cunningpac CC

Cunningpac CC — FEI 3013867848

The FDA completed an inspection of Cunningpac CC on Dec 7, 2018 in Pietermaritzburg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 10 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 7, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pietermaritzburg (South Africa)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117721 CFR 211.63Equipment Design, Size and Location
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
136121 CFR 211.100(a)Absence of Written Procedures
154021 CFR 211.125(a)Strict control not exercised over labeling issued
176721 CFR 211.137(a)Expiration date lacking
184221 CFR 211.84(d)(1)Component identity verification
188321 CFR 211.165(a)Testing and release for distribution
197521 CFR 211.182Written records kept in individual logs
2129621 CFR 211.186(a)Master production and control records, batch uniformity

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.